Darzi review will find lack of capital expenditure since 2010s has stunted NHS modernisation and worsened backlogs
Medical breakthroughs come with spiralling price tag, leaving policymakers with tough decisions
Wes Streeting tells FT Weekend festival that people ‘are not living well longer’
Health MOTs can flag risks but it might be too much to ask staff to step on the scales
Farmers fear for livelihoods as government struggles to stem worst outbreak of virus in decades
Education leaders warn of crisis as teachers struggle to meet demand from pupils with complex needs
Scientists develop model to analyse tumours, treatments and survival rates
European Court of Auditors says closer co-operation on data and testing would help fix shortcomings exposed by Covid
An emotionally compelling account of the traumatic and miraculous ramifications of an organ transplant
US telehealth groups including Hims & Hers and Ro could find new revenue streams under threat
Scientists’ goal is not to resurrect vanished creatures but discover whether ancient molecules can solve modern problems
Meet the functional medicine practitioner dubbed ‘Queen of the Reset’
In everything from nursing to anaesthesia, medical systems worldwide are relying on support staff more than ever. Are there dangers to our health?
Labour’s spending review must apply this test to every departmental proposal
Groups managing more than $13tn cite ‘economic imperative’ of finding ways to reduce superbugs’ spread
Also in this newsletter: the Netherlands refuses to donate mpox vaccines to Africa
Report says number of procedures double from 2019-2022 as Britons seek faster treatment outside state sector
The UK government needs to look abroad for inspiration
Care home costs have been rising steeply
Comments set to throw renewed spotlight on issue Democrats have targeted Republican presidential candidate over
A three-part FT series looks at how an influx of money is changing prospects for patients but creating new challenges for healthcare systems
Pandemic winners BioNTech and Moderna face hurdles as they seek to bring their groundbreaking technology to oncology
More trials urged as part of effort to slow cognitive declines with existing medicines
Wealthy world must help Africa prevent a potential regional health catastrophe
Nice’s ruling on lecanemab demonstrates the lack of readiness to roll out new treatments in the UK
